AI in Pharma

Pavel Trofimov

Why Great Science Doesn't Sell Itself: Clinical Research's Commercial Blind Spot

Pavel Trofimov, founder of Lab-2-Business, joins Adam Walker to explore why great science doesn't sell itself, the limits of founder-led growth, embedded commercial teams and why AI-native clinical research companies are selling behaviour change.

Leadership & Career

Henrik Nakskov

An AI Can't Ask Questions of the Future: Data Trust in Clinical Research

Henrik Nakskov, CEO of Novyra Life Sciences and founder of CIMS Consult, draws on 20+ years in clinical data management at Novo Nordisk, NNIT and Symphogen to explain data trust, AI guardrails and continuous monitoring in clinical research.

Clinical Trials

Dr Sonit Handa

From Physician in India to Building a $1M-a-Day Children's Cancer Tissue Bank

Dr Sonit Handa traces his path from physician training in India to building the operations behind St Jude Children's Research Hospital's cancer tissue bank, then leading biopharma launches and transformation through Biovance Consulting.

Leadership & Career

Gerrie Hawes

The HOPE Framework, Behaviour Change & Why Strategy Alone Never Sticks

Gerrie Hawes — corporate behavioural psychologist and creator of the HOPE framework — joins Adam Walker to explain why behaviour, not strategy, actually changes organisations. The family photograph that reframed an IT leader's opening speech, Happiness, Optimism, Playfulness and Empathy as a working model, the laughter that signals a safe room, extreme role modelling, boundaries and burnout, upward empathy, and why playfulness and genuine empathy are the human advantages AI cannot copy.

Leadership & Career

Ashish Rishi

Inclusion Debt, Equity Engine & the Patients Trials Leave Out

Ashish Rishi — founder and CEO of Unwritten Health — joins Adam Walker to explain "inclusion debt": how bias compounds at every stage of drug development, from unmet need defined without the real patient voice, to multi-billion-pound programmes built on focus groups of eight to ten patient experts, to recruitment budgets thrown at social ads that only reach the already-reachable. Also in this episode: the two-minute conversation that told an 18-year-old his father had terminal prostate cancer, the Equity Engine panel of 6,500 UK participants profiled across the social determinants of health, AI analysis that tears apart a tone-deaf recruitment flyer, UK health data fragmentation, and what a neurodivergent-friendly clinical research unit would actually look like.

Patient Voice

Louise Callin

Dementia, Photos Sparking Conversation & Making Care More Human

Louise Callin — founder and CEO of ReelLife Conversations — joins Adam Walker to explain how a photograph can become a conversation rather than a memory test. After nearly 30 years leading technology and transformation in global corporations, Louise left to build a social care technology platform inspired by her mum's dementia journey: photos grouped by face and place, AI-generated conversation prompts, and linked images that keep a conversation flowing. Also in this episode: accessible design for dementia, why 'I remember when' beats 'do you remember', the disproportionate caregiving load carried by women, and taking a values-driven business through venture capital investment.

Patient Voice

Andreas Beust

How a Small CRO Covers the Globe Without Growing

Andreas Beust — CEO and Managing Director of GCP Service International in Bremen and President of ACROS, the Association of International CROs — joins Adam Walker to explain how a small CRO can run trials globally without ballooning in size. Ten similarly sized, like-minded CROs across the US, Europe, the Middle East, India, China and Australia agree that once a partner joins, their country is off-limits to the others: grow together, not bigger. Also in this episode: from the biostatistics desk to the CEO's office, hiring for attitude, leading without ego, a frank reality check on AI in clinical trials, and why discomfort is what actually drives growth.

Clinical Trials

Adam Walker

GMP, Sepsis & 900k NHS Doses a Year

Host Adam Walker meets his namesake — Qualified Person, NHS pharmacist and Head of Development & Innovation at the North East and North Cumbria Medicines Manufacturing Centre. They cover Specials manufacturing, the new aseptic pathfinder hub gearing up for 150,000 chemotherapy and 750,000 IV antibiotic doses a year, the door-to-needle sepsis window, the personal loss driving the mission, and the Help Me GMP platform training the next generation.

Healthcare Systems

Alen Lalic

Clinical Trial Scan, Dyno AI & Engineering Patient Enrollment

Alen Lalic — founder and CEO of Clinical Trial Scan and creator of Dyno AI — joins Adam Walker for a masterclass in patient recruitment as an engineered system. Former Olympic fencer, ex-affiliate advertiser with $5–7M of clinical trial ad data behind him, Alen breaks down his seven-step enrollment funnel, why hot leads beat cold databases, how his Medellín call team converts in the evening blocks the industry sleeps through, and the patent-pending cost-per-enrollment model behind it all.

Clinical Trials

Andy York

AI, Data Science & Why 80% Accuracy Isn't Good Enough

Today's guest is Andy York, one of the most respected voices in global statistical programming and clinical data science. Andy shares 30+ years of lessons — from paper CRFs to AI guardrails, the shift from SAS to R, and what the next generation of pharma programmers must learn to stay relevant.

AI & Technology

Bilal Bham

Life Sciences Strategy, Human Perspective & Building Amodaia

Today's guest is Bilal Bham, founder and CEO of Amodaia, a senior-led life science consultancy supporting biotech, pharma, and medtech teams at critical decision points across regulatory affairs, medical affairs, market access, marketing communications, and fundraising. With nearly two decades in life sciences, Bilal brings both strategic clarity and a human perspective shaped by lived experience.

AI & Technology

Adam Baumgart

RBQM, AI in Clinical Trials & 38 Years of Hard-Won Pharma Wisdom

Today's guest is Adam Baumgart, an advisor and consultant at ZS Associates and Alcedo Consulting whose passion is enhancing risk-based quality management and clinical trial processes. Drawing on 35 years of CRO and pharma experience, including leadership roles at AstraZeneca and Covance, Adam provides strategic input on AI models to optimize RBQM, clinical data review, and site monitoring.

Clinical Trials

Steven Thompson

AI, Clinical Trial Activation & Why 85% of Trials Are Delayed

Today's guest is Steven Thompson, who spent more than two decades reshaping how clinical research actually gets done. He's the founder of Next trial AI and a leading voice at the intersection of AI trial activation and human-centered design in healthcare.

AI & Technology

Scott Schliebner

DCTs, Patient-Centric Trials & 30 Years of Pharma Innovation

Today's guest is Scott Schliebner, who is a seasoned biopharma executive with nearly 30 years of experience spanning biotech, CROs and nonprofit life science organizations. He currently serves as CEO and founder of Ascent Biostrategies and previously has worked at Novatech and various other companies.

AI & Technology

Amelia Wrighton

Suicide Loss, Grief & the Charity That Helped Adam's Family

Today's guest is Amelia Wrighton, who is the co-founder and CEO of the charity, suicide and Co. Her commitment to suicide bereavement is rooted in her lived experience and is a powerful thread running through her work and her leadership.

Mental Health & Wellbeing

Helene Quie

MedTech Regulation, Danish Innovation & Getting Devices to Patients

Today's guest is Helene Quie, who is a strategic decision maker, founder and CEO of qm, med Consulting, a global healthcare consultancy, CRO, driving medical device innovation with more than 25 years at the intersection of science regulation and commercial strategy.

Founders & MedTech

Sylvain Berthelot

Patient-Centricity, Korean Innovation & Simplifying Trials

Today's guest is Sylvain Berthelot, who is a clinical technology and life science professional with deep expertise in clinical systems and the digital ecosystem that supports modern clinical research.

Clinical Trials

Thibault Geoui

AI, Drug Discovery What Next Generation of Scientists Must Learn

Today's guest is Thibault Geoui, dr. Tebo z, host of the acclaimed Tech and Drugs podcast, and a driving force at the intersection of biotech innovation and digital transformation. His podcast has become a go-to platform for unpacking the future of pharma, where Thibault brings a rare blend of scientific insight and startup savvy.

AI & Technology

Jura Lasas

Rare Disease, Patient Advocacy & a One-Way Ticket to America

Today's guest is Jurate Lasiene, who is a clinical research leader and biotech consultant specializing in rare disease clinical operations for small biopharma and biotech companies with over 20 years bridging academia and industry. She's become the operational compass for biotech's, navigating early clinical trials.

Patient Voice

Duncan Kemp

Redundancy, Reinvention & 20 Years of Clinical Software

Today's guest is Duncan Kemp, who is the founder of Software Solutions, a software consultancy firm with a mission to empower life science businesses with innovative and reliable solutions that drive efficiency, enhanced productivity, and foster growth.

Founders & MedTech

Tom Farrand

AI Agents, Patient Recruitment Building Delfa from Cockroach Hotel

Today's guest is Tom Farrand, who has worked throughout his career at the intersection of AI and life sciences. First at IBM, helping university hospitals to use supercomputers to model 3D hot scans. Then joining leading startups.

Patient Voice

Poorya Amini

Protocol AI, 800k Clinical Trials & Why Pharma Does It Wrong

Today's guest is Poorya Amini, founder and CEO of Risklick A Swiss digital health company that's redefining how clinical trial protocols are designed Poorya's, journey spans veterinary medicine, a PhD in pharmacology. And hands-on experience managing trials at the University of Burn.

AI & Technology

Anna Maxwell

Drug Reclassification, Women's Health & OTC Contraceptive Pill

Today's guest is Anna Maxwell, who is a mission-driven founder, pharmacist, and entrepreneur dedicated to widening access to medicines and empowering people to take more control of their health. She's the CEO and founder of Maxwellia, one of the UK's most ambitious, emerging consumer healthcare companies.

Founders & MedTech

Matt Veatch

Real World Data, Phenotypes & Why Precision Beats Big Data

Today's guest is Matt Veatch, co-founder and COO of Navidence, and a driving force behind the Real World Wednesday's podcast, a weekly forum that's shaping how we think about real world data and real world evidence.

AI & Technology

Nives Rombini

AI, Drug Discovery & Building a Profitable Start-up

Today's guest is Nives Rombini, who is a scientist, data strategist and founder whose career bridges molecular biology, immunology, and advanced analytics. Nives leads Navis Bio, a venture dedicated to harnessing data-driven insights for biomedical innovation.

Leadership & Career

Alan Salter

Military Service, Servant Leadership & Brilliance at the Basics

Today's guest is Alan Salter, who is a professional whose career spans military service, international business and healthcare leadership. A proud US Navy veteran. Alan served with distinction before transitioning into the private sector where he established a management consulting company.

Leadership & Career

Maya Zlatanova

Designing Trials for Real Patients (Not Unicorns)

Today's guest is Maya Zlatanova, a visionary leader in clinical research and host of the podcast trials with Myers Z, where she explores the future of trials with global experts and patient advocates as CEO and Co-founder of Find Me Cure and Trial Hub, Maya is on a mission to make clinical trials more accessible, transparent, and patient-centric.

Patient Voice

Dr. Daniel Fox

Research Deserts & Building CRPN to Fix Clinical Trial Access

Today's guest is Dr. Daniel Fox, who is the CEO of CRPN Central, and a leader in redefining clinical research through decentralized patient first platforms. With a background in medicine policy and digital innovation, Dr. Fox is building scalable ecosystems that restore trust and transparency in trials.

Leadership & Career

Wendy Turenne

Real World Evidence, Messy Data & Why AI Must Earn Your Trust

Today's guest is Wendy Turenne, widely known in the industry as Real World Wendy. A strategic force in real world data and evidence generation, she most recently served as Chief Data Officer and SVP of Evidence Solutions at Aeon, where she led global teams in transforming real world data into regulatory-grade evidence.

Clinical Trials

Jan Krikava

Docuply, Affordable QMS & Why Small Pharma Deserves Better Tools

Today's guest is Jan Krikava, co-founder and managing director of Docu Ply, a document automation platform purpose built for the pharmaceutical and healthcare sectors with a degree in software engineering and a background in enterprise.

Clinical Trials

Dr. Andree Bates

Pharma AI, Saving Lives with Data, HelloFresh of Medicine

Today's guest is Dr Andree Bates, who is a pioneering force in pharmaceutical ai. She's known for transforming how life science companies harness data to drive growth, innovation, and patient outcomes. As founder and CEO of Eularis, Dr.

AI & Technology

Sverre Bengtsson

Building Viedoc, Airport Deal & Why Europe Must Work Together

Today's guest is Sverre Bengtsson, who is a trailblazer in clinical trial innovation and digital transformation. As co-founder at Viedoc Technologies, he's helped shape one of the most widely adopted eClinical platforms in the world, streamlining trials across more than 80 countries, and empowering thousands of research teams to work smarter and faster.

AI & Technology

Nuria Coll Bastus

Trial Matching in 5 Minutes & Why 80% of Trials Are Delayed

Today's guest is Nuria Coll Bastus, who is an industry disruptor whose roots in academic research and onco genomics have blossomed into a bold new vision for clinical trials. Born in Spain and now based in the uk. Noria brings a cross-cultural lens to one of farmer's most persistent challenges.

Patient Voice

Artem Adrianov

RBQM, Fraud Detection & Young CEO Program Outperforming MBAs

Today's guest is Artem Adrianov, mathematician strategist, Risk-Based Quality Management, trailblazer as co-founder and CEO of Integrity. He spent over 25 years transforming clinical trials through data intelligence and risk-based methodologies.

Clinical Trials

Steve Sanghera

Inventus, Purpose-Built Devices & an Obsession Over Rivets

Today's guest is Steve Sanghera, who is the CEO of Inventus, a UK based innovator redefining how clinical trials are powered through secure provisioned mobile devices. With a background steeped in digital transformation, Steve leads Inventus in delivering smartphones and tablets.

Founders & MedTech

Dr. Berry Pierre

Main Character Energy, 2k YouTube Vids & Trust in Healthcare

Today's guest is Dr. Berry Pierre, a board-certified internist, national speaker, and host of the Lunch and Learn podcast. With over 15 years of clinical experience, he's treated patients across hospitals, rehab centers, and nursing homes, tackling everything from infectious diseases to chronic conditions.

Patient Voice

Leigh Fell

Caritas Bioscience, Corporate Athleticism & Wellbeing Isn't a Perk

Today's guest is Leigh Fell, who is a trailblazer in clinical research, a champion of corporate wellbeing and the visionary founder of Caritas. Leigh's journey from managing oncology trials to building a purpose-driven CRO is a masterclass in blending scientific vigor.

Founders & MedTech

Wessam Sonbol

Delve Health & Why Clinical Trials Failed His Mother

Today's guest is Wessam Sonbol, CEO of Delve Health, a pioneering force in digital health and decentralized trials. Leading a groundbreaking platform that supports clinical research in 65+ languages, Wessam is revolutionizing patient access to clinical trials through innovative integration of wearables, telehealth, and AI-powered solutions.

AI & Technology

Belma Alispahic

SimCell, Digital Twins & Why AI Isn't Optional Anymore

Today's guest is Belma Alispahic, co-founder and Chief Scientific Officer of Analysis Mode. With a master's in applied biotechnology from UPS University, she has a track record of turning complexity into clarity and is reshaping how we think about bioprocess development.

Founders & MedTech

Charlotte Chadwick

Clinology, 25 Years in Clinical & Consultant Visibility

Today's guest is Charlotte Chadwick, founder of Clinology, a consultancy helping pharma rethink trials through the lens of operational depth and human centered design. Charlotte brings over 25 years of experience in clinical research spanning senior roles across CROs, sponsors, and consultancies.

Leadership & Career

Anders Mortin

Triticon, Knowledge World & 25 Years of Accidental Pharma

Today's guest is Anders Mortin, who is a seasoned eClinical professional with over two decades of experience in clinical development processes and systems known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions.

AI & Technology

Matthew Mace

Study Connect, Why Pharma Needs MedTech Outsiders in Cardiology

Today's guest is Matthew Mace, who is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts. Founder of Study Connect, Inc. Where he's on a mission to streamline scientific innovation through faster trials and smarter collaboration.

Founders & MedTech

Philip Morisky

Medication Adherence & Why Healthcare's Metrics Must Be Fixed

Today's guest is Philip Morisky, who serves as Chief Optimist at Adherence, leading the company's mission to revolutionize global medication adherence.

Healthcare Systems